ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2013
Management of type 2 diabetes mellitus in older patients: current and emerging treatment options.
Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Consideration of inequalities in effectiveness trials of mHealth applications - a systematic assessment of studies from an umbrella review.International journal for equity in health · 2024Pooled it
- Practices and Insights for Diabetes Mellitus Testing in Sri Lanka, Singapore and the Philippines.EJIFCC · 2025Article
- Biomarker Signatures of Two Phenotypical Prefrailty Types in the Irish Longitudinal Study on Ageing.Geriatrics (Basel, Switzerland) · 2022Article
- Behavioral Sciences in the Optimization of Pharmacological and Non-Pharmacological Therapy for Type 2 Diabetes.Behavioral sciences (Basel, Switzerland) · 2021Review
- Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.Cardiovascular diabetology · 2021Article
- Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A subanalysis of a post-marketing study (J-STEP/EL Study).Journal of diabetes investigation · 2020Observational
- Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3).Diabetes, obesity & metabolism · 2019Article
- Burden of Illness in Type 2 Diabetes Mellitus.Journal of managed care & specialty pharmacy · 2018Review
- Similar Efficacy and Safety of BasaglarDiabetes therapy : research, treatment and education of diabetes and related disorders · 2018Article
- Persistence With Oral Antihyperglycemic Drugs in Type 2 Diabetes Mellitus Patients With Dementia in Germany.Journal of diabetes science and technology · 2018Article
- Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post-marketing study (J-STEP/EL Study).Journal of diabetes investigation · 2017Observational
- Hemoglobin ADiabetes care · 2017Observational
- Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand.Therapeutic advances in drug safety · 2016Article
- Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand.ClinicoEconomics and outcomes research : CEOR · 2016Article
- Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus.Journal of diabetes investigation · 2015Article
- Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.Diabetes care · 2015Article
- Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.Clinical interventions in aging · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elderly patients with type 2 diabetes mellitus (T2DM) are a rapidly emerging population that presents unique clinical challenges. This diverse patient group can differ widely in terms of physical and mental status, which can increase their risk of complications including hypoglycemia, falls, and depression. These factors can negatively impact their glycemic control, safety, and quality of life. The risk of hypoglycemic events is elevated among elderly patients with diabetes. In many cases, these events are related to antidiabetic therapy and the pursuit of strict glycemic control. Fear of a hypoglycemic episode, on the part of the patient and/or healthcare provider, is another major barrier to achieving glycemic control. Hypoglycemic events, even in the absence of awareness of the event (asymptomatic), can have negative consequences. To help manage these risks, several national and international organizations have proposed guidelines to address individualized treatment goals for older adults with diabetes. This article reviews current treatment guidelines for setting glycemic targets in elderly patients with T2DM, and discusses the role of emerging treatment options in this patient population.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.